scholarly journals Treatment Patterns for Parkinson’s Disease: Real-World Evidence from the EU5 (France, Germany, Italy, Spain, and the United Kingdom)

2013 ◽  
Vol 16 (7) ◽  
pp. A630
Author(s):  
A.H. Sung ◽  
A. Kulkarni ◽  
P. Svarvar
2020 ◽  
Vol 2020 ◽  
pp. 1-11 ◽  
Author(s):  
Emma Tenison ◽  
Agnes Smink ◽  
Sabi Redwood ◽  
Sirwan Darweesh ◽  
Hazel Cottle ◽  
...  

Parkinson’s disease is the second most common neurodegenerative condition after Alzheimer’s disease. The number of patients will rise dramatically due to ageing of the population and possibly also due to environmental issues. It is widely recognised that the current models of care for people with Parkinson’s disease or a form of atypical parkinsonism lack continuity, are reactive to problems rather than proactive, and do not adequately support individuals to self-manage. Integrated models of care have been developed for other chronic conditions, with a range of positive effects. A multidisciplinary team of professionals in the United Kingdom and the Netherlands, all with a long history of caring for patients with movement disorders, used knowledge of deficiencies with the current model of care, an understanding of integrated care in chronic disease and the process of logic modelling, to develop a novel approach to the care of patients with Parkinson’s disease. We propose a new model, termed PRIME Parkinson (Proactive and Integrated Management and Empowerment in Parkinson’s Disease), which is designed to manage problems proactively, deliver integrated, multidisciplinary care, and empower patients and their carers. It has five main components: (1) personalised care management, (2) education and empowerment of patients and carers, (3) empowerment of healthcare professionals, (4) a population health approach, and (5) support of the previous four components by patient- and professional-friendly technology. Having mapped the processes required for the success of this initiative, there is now a requirement to assess its effect on health-related and quality of life outcomes as well as determining its cost-effectiveness. In the next phase of the project, we will implement PRIME Parkinson in selected areas of the United Kingdom and the Netherlands.


2003 ◽  
Vol 66 (5) ◽  
pp. 193-200 ◽  
Author(s):  
K H O Deane ◽  
C Ellis-Hill ◽  
K Dekker ◽  
P Davies ◽  
C E Clarke

Little is known about the current character of occupational therapy practice for Parkinson's disease in the United Kingdom. The study aimed to document this in order to inform plans for a future multicentre randomised controlled trial. Two hundred and forty-two occupational therapists that treated people with Parkinson's disease were sent a questionnaire regarding demographics, service organisation and therapy content. One hundred and sixty-nine occupational therapists (70%) responded. They had worked with people with Parkinson's disease for a median of 6 years and personally treated a median of 15 people with Parkinson's disease annually. Most (86%) were at senior grade or above; 87% worked in the National Health Service and 12% in social services. Forty per cent worked in specialist Parkinson's disease clinics. Most (79%) felt that they needed more specialist postgraduate training. Occupational therapists are employed in both health and social care settings. The character of the occupational therapy is often determined by the location in which it is provided. Current occupational therapy appears to focus on functional activities rather than on the wider social and psychological aspects of occupation. Many occupational therapists felt that they needed more specialist postgraduate training to treat people with Parkinson's disease effectively.


2011 ◽  
Vol 18 (12) ◽  
pp. 1746-1747 ◽  
Author(s):  
Rahul Potluri ◽  
Ammar Natalwala ◽  
Mitsuko Nakajima ◽  
Deepthi Lavu ◽  
Rochelle Velho ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document